Latest editorial
by Our News Desk
THE Competition and Markets Authority (CMA) announced a new probe into drug firms Pfizer and Flynn Pharma yesterday for allegedly charging “excessive and unfair prices” for epilepsy medication.
Pharmaceutical giant Pfizer and distributor Flynn Pharma are being investigated to see whether the two companies abused their dominant position over the pricing of epilepsy drugs in breach of both British and EU competition law.
1943-2025: How one man’s unfinished work reveals the lethal lie of ‘colour-blind’ medicine
Politicians who continue to welcome contracts with US companies without considering the risks and consequences of total dependency in the years to come are undermining the raison d’etre of the NHS, argues Dr JOHN PUNTIS
US tariffs have had Von der Leyen bowing in submission, while comments from the former European Central Bank leader call for more European political integration and less individual state sovereignty. All this adds up to more pain and austerity ahead, argues NICK WRIGHT
